Gene Therapy for Endothelial Progenitor Cell Dysfunction
Endothelial progenitor cells (EPCs) have reduced neovascularization capacity in the context of coronary artery disease (CAD) or cardiac risk factors (RFs). Since, endothelial NO synthase (eNOS) is critical to normal EPC function, we hypothesized that bone marrow cells (BMCs) from rats with RFs and E...
Main Author: | Ward, Michael Robert |
---|---|
Other Authors: | Stewart, Duncan John |
Language: | en_ca |
Published: |
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/19108 |
Similar Items
-
Gene Therapy for Endothelial Progenitor Cell Dysfunction
by: Ward, Michael Robert
Published: (2009) -
Endothelial Progenitor Cells (EPCs) for Fracture Healing and Angiogenesis: A Comparison with Mesenchymal Stem Cells (MSCs)
by: Nauth, Aaron
Published: (2012) -
Endothelial Progenitor Cells (EPCs) for Fracture Healing and Angiogenesis: A Comparison with Mesenchymal Stem Cells (MSCs)
by: Nauth, Aaron
Published: (2012) -
Multigene Therapy by Ultrasound-mediated Plasmid Delivery: Temporally Separated Delivery of Vascular Endothelial Growth Factor and Angiopoietin-1 Promotes Sustained Angiogenesis in Chronically Ischemic Skeletal Muscle
by: Smith, Alexandra Helen
Published: (2010) -
Multigene Therapy by Ultrasound-mediated Plasmid Delivery: Temporally Separated Delivery of Vascular Endothelial Growth Factor and Angiopoietin-1 Promotes Sustained Angiogenesis in Chronically Ischemic Skeletal Muscle
by: Smith, Alexandra Helen
Published: (2010)